525 related articles for article (PubMed ID: 16807767)
1. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
[TBL] [Abstract][Full Text] [Related]
2. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
Sasaki MS; Endo S; Hoshi M; Nomura T
J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
[TBL] [Abstract][Full Text] [Related]
3. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.
Sasaki MS; Nomura T; Ejima Y; Utsumi H; Endo S; Saito I; Itoh T; Hoshi M
Radiat Res; 2008 Jul; 170(1):101-17. PubMed ID: 18582156
[TBL] [Abstract][Full Text] [Related]
4. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
Rühm W; Walsh L; Chomentowski M
Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
[TBL] [Abstract][Full Text] [Related]
5. Biological effectiveness of neutrons from Hiroshima bomb replica: results of a collaborative cytogenetic study.
Dobson RL; Straume T; Carrano AV; Minkler JL; Deaven LL; Littlefield LG; Awa AA
Radiat Res; 1991 Nov; 128(2):143-9. PubMed ID: 1947011
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Relative Biological Effectiveness of Neutrons across Organs of Varying Depth among the Atomic Bomb Survivors.
Cordova KA; Cullings HM
Radiat Res; 2019 Aug; 192(4):380-387. PubMed ID: 31390313
[TBL] [Abstract][Full Text] [Related]
7. Stable chromosome aberrations among A-bomb survivors: an update.
Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
[TBL] [Abstract][Full Text] [Related]
8. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
Brenner DJ
Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
[TBL] [Abstract][Full Text] [Related]
9. Relative biological effectiveness of 144 keV neutrons in producing dicentric chromosomes in human lymphocytes compared with 60Co gamma rays under head-to-head conditions.
Schmid E; Regulla D; Guldbakke S; Schlegel D; Roos M
Radiat Res; 2002 Apr; 157(4):453-60. PubMed ID: 11893248
[TBL] [Abstract][Full Text] [Related]
10. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
Kellerer AM; Nekolla E
Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
[TBL] [Abstract][Full Text] [Related]
11. Accounting for neutron exposure in the Japanese atomic bomb survivors.
Cullings HM; Pierce DA; Kellerer AM
Radiat Res; 2014 Dec; 182(6):587-98. PubMed ID: 25409123
[TBL] [Abstract][Full Text] [Related]
12. Neutron energy-dependent initial DNA damage and chromosomal exchange.
Tanaka K; Gajendiran N; Endo S; Komatsu K; Hoshi M; Kamada N
J Radiat Res; 1999 Dec; 40 Suppl():36-44. PubMed ID: 10804992
[TBL] [Abstract][Full Text] [Related]
13. RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS DERIVED FROM THE EXCESS RELATIVE RISK MODEL WITH THE ATOMIC BOMB SURVIVORS DATA MANAGED BY HIROSHIMA UNIVERSITY.
Satoh K; Yasuda H; Kawakami H; Tashiro S
Radiat Prot Dosimetry; 2018 Aug; 180(1-4):346-350. PubMed ID: 29036656
[TBL] [Abstract][Full Text] [Related]
14. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
15. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
[TBL] [Abstract][Full Text] [Related]
16. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
[TBL] [Abstract][Full Text] [Related]
17. Evidence of a neutron RBE of 70 (+/- 50) for solid-tumor induction at Hiroshima and Nagasaki and its implications for assessing the effective neutron quality factor.
Zaider M
Health Phys; 1991 Nov; 61(5):631-6. PubMed ID: 1752746
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
Otake M
J Radiat Res; 1979 Dec; 20(4):307-21. PubMed ID: 536952
[No Abstract] [Full Text] [Related]
19. Neutron-induced 63Ni in copper samples from Hiroshima and Nagasaki: a comprehensive presentation of results obtained at the Munich Maier-Leibnitz Laboratory.
Rühm W; Carroll KL; Egbert SD; Faestermann T; Knie K; Korschinek G; Martinelli RE; Marchetti AA; McAninch JE; Rugel G; Straume T; Wallner A; Wallner C; Fujita S; Hasai H; Hoshi M; Shizuma K
Radiat Environ Biophys; 2007 Nov; 46(4):327-38. PubMed ID: 17828415
[TBL] [Abstract][Full Text] [Related]
20. High-energy gamma rays in Hiroshima and Nagasaki: implications for risk and WR.
Straume T
Health Phys; 1995 Dec; 69(6):954-6. PubMed ID: 7493812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
